ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Adult Health

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,952Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 67

$440K Total Retail Price of All Prescriptions

Rank: 6 out of 67

329 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
58% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 329 patients filled at least one prescription for a schedule two drug, compared to an average of 16%.

Schedule Three
Controlled Substances

22% of this provider’s 329 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

1% of this provider’s 7,722 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
WARFARIN SODIUM 488 396 1 12
LISINOPRIL 402 361 2 2
HYDROCODONE-ACETAMINOPHEN 371 319 S3 3 1
LEVOTHYROXINE SODIUM 338 311 4 4
OMEPRAZOLE 318 284 5 5
POTASSIUM CHLORIDE 304 281 6 18
SIMVASTATIN 290 262 7 3
FUROSEMIDE 241 221 8 7
METFORMIN HCL 228 190 9 8
METOPROLOL TARTRATE 220 213 10 9
CITALOPRAM HBR 183 165 11 21
AMLODIPINE BESYLATE 149 142 12 6
METOPROLOL SUCCINATE 139 139 13 13
MORPHINE SULFATE ER 138 135 S2 14 25
OXYCODONE HCL 134 61 S2 15 10
HYDROCHLOROTHIAZIDE 130 124 16 11
TRAZODONE HCL 114 101 17 23
LANTUS 102 88 18 27
ATENOLOL 95 79 19 14
GABAPENTIN 94 78 20 16
ADVAIR DISKUS 93 76 21 37
LOVASTATIN 92 88 22 15
POLYETHYLENE GLYCOL 3350 89 83 23 63
METHADONE HCL 74 20 S2 24 40
CIPROFLOXACIN HCL 74 71 24 45
LOSARTAN POTASSIUM 73 70 26 19
SERTRALINE HCL 71 71 27 28
ESCITALOPRAM OXALATE 70 56 28 51
NAMENDA 68 66 29 69
PROAIR HFA 66 43 30 50
TAMSULOSIN HCL 63 62 31 71
FLUTICASONE PROPIONATE 62 59 32 54
CHLORTHALIDONE 60 60 33 111
ZOLPIDEM TARTRATE 60 52 33 30
DONEPEZIL HCL 59 56 35 64
GLIMEPIRIDE 57 51 36 31
PAROXETINE HCL 55 25 37 55
ATORVASTATIN CALCIUM 55 49 37 17
SPIRONOLACTONE 53 49 39 52
CRESTOR 53 46 39 42
RANITIDINE HCL 50 49 41 32
PRAVASTATIN SODIUM 50 50 41 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 2, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.